Frédérique Berger
0000-0002-3251-4060
3 papers found
Refreshing results…
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma
Missing publications? Search for publications with a matching author name.